CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.

CoreRx Scientific Leadership Team Adds Michael Grass, Ph.D.

CLEARWATER, FL– CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product Innovation.

Michael brings over eleven years of experience in R & D in particle engineering, and in product development utilizing enhanced formulations, with Bend Research, Capsugel and Lonza. Michael earned his B.A. in Chemistry from Pomona College and his Ph.D. in Physical Chemistry from the University of California, Berkeley. Further, Michael performed post-doctorate research in material sciences and x-ray spectroscopy at the Lawrence Berkeley National Laboratory in Berkeley, CA.  In his new role, Michael will partner with pharmaceutical organizations on product development, technology development, and the development of innovative drug delivery systems.

“We continue to expand our West Coast organization and our pharmaceutical development capabilities.  Our recent investments and additions are in response to partners asking for expanded capabilities in early phase drug development, partnerships in technology development, and an increased presence on both U.S. coasts”, said Ajay Damani, CEO of CoreRx, Inc. “We are excited to welcome Michael to the CoreRx team.”  CoreRx previously announced the additions of Amber Broadbent, Ph.D. and Scott Bone, M.S. to its West Coast product development organization.

ABOUT:  CoreRx, Inc. is an industry leading Contract Development and Manufacturing Organization (CDMO), providing innovative drug formulation, development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From its state-of-the-art, multi-site campus in Clearwater, Florida and its early product development center in San Rafael, California, CoreRx delivers value-added solutions to its partners, from clinic to commercial scale, across a range of dosage forms.

For more information on CoreRx, please visit and follow CoreRx on LinkedIn 

William Sirico, Director of Marketing